Localization of Thrombospondin in Clots Formed in Situ
Overview
Authors
Affiliations
Thrombospondin is a principal glycoprotein secreted by thrombin-stimulated platelets and has known affinities for fibrinogen and fibrin. We studied the distribution of thrombospondin in clots formed in situ on Formvar-coated coverslips at 37 degrees C for intervals up to 17 hours. The distributions of three other major platelet granular proteins--fibrinogen, fibronectin, and von Willebrand factor (vWF)--were also determined. The portions of the clots adhering to the coverslips after stripping, washing, and fixation with formaldehyde were stained for the four proteins by the peroxidase-antiperoxidase technique. Monoclonal antibodies were used to localize thrombospondin, fibronectin, and vWF; affinity-purified polyclonal antibodies were used to localize fibrinogen. Platelets stained positively for all four proteins. Thrombospondin was maximally present in the fibrin meshwork from 1 1/2 to 2 hours, after which the intensity of staining decreased until only trace amounts of thrombospondin were detectable between four and 17 hours. Antifibrinogen and, to a lesser extent, antifibronectin stained the fibrin meshwork at all time points. The vWF was not detectable in the fibrin meshwork at any time point. Staining of polymorphonuclear leukocytes (PMNLs) in a fine granular pattern was found with antithrombospondin. The fraction of PMNLs staining positively was 6% to 14% at 1/2 to 4 hours and increased at eight hours to 27%. At 17 hours, 52% of the PMNLs stained for thrombospondin. More than 48% of the PMNLs stained with antifibrinogen at all time points. PMNLs did not stain for either fibronectin or vWF. These studies indicate that thrombospondin is a transient component of the temporary fibrin meshwork and has a unique spatial and temporal distribution in the hemostatic plug.
Dual Role of Thrombospondin-1 in Flow-Induced Remodeling.
Grenier C, Caillon A, Munier M, Grimaud L, Champin T, Toutain B Int J Mol Sci. 2021; 22(21).
PMID: 34769516 PMC: 8584526. DOI: 10.3390/ijms222112086.
Penaloza H, Olonisakin T, Bain W, Qu Y, van der Geest R, Zupetic J mBio. 2021; 12(2).
PMID: 33824208 PMC: 8092289. DOI: 10.1128/mBio.03336-20.
Wang J, Yu X, Ouyang N, Zhao S, Yao H, Guan X Front Oncol. 2019; 9:1029.
PMID: 31649886 PMC: 6794608. DOI: 10.3389/fonc.2019.01029.
Atomic Force Microscopy Is a Potent Technique to Study Eosinophil Activation.
Eaton P, Pais do Amaral C, Couto S, Oliveira M, Vasconcelos A, Borges T Front Physiol. 2019; 10:1261.
PMID: 31632296 PMC: 6781654. DOI: 10.3389/fphys.2019.01261.
Yun S, Kim S, Kim E Front Pharmacol. 2019; 10:162.
PMID: 30873033 PMC: 6400889. DOI: 10.3389/fphar.2019.00162.